Sélection de la langue

Search

Sommaire du brevet 2878256 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Demande de brevet: (11) CA 2878256
(54) Titre français: DISPOSITIF DE BUSE ET DISPOSITIF D'INJECTION MINIMALEMENT INVASIF LE COMPRENANT
(54) Titre anglais: NOZZLE DEVICE AND MINIMALLY INVASIVE INJECTION DEVICE COMPRISING SAME
Statut: Réputée abandonnée et au-delà du délai pour le rétablissement - en attente de la réponse à l’avis de communication rejetée
Données bibliographiques
(51) Classification internationale des brevets (CIB):
  • A61M 5/31 (2006.01)
  • A61K 8/30 (2006.01)
  • A61M 5/30 (2006.01)
  • A61M 5/315 (2006.01)
  • A61M 37/00 (2006.01)
(72) Inventeurs :
  • PARK, JIN WOO (Republique de Corée)
  • KWON, MIN KYOUNG (Republique de Corée)
  • JANG, JI HYE (Republique de Corée)
  • BAE, JOON HO (Republique de Corée)
  • CHOI, JIN KYU (Republique de Corée)
(73) Titulaires :
  • AMOREPACIFIC CORPORATION
(71) Demandeurs :
  • AMOREPACIFIC CORPORATION (Republique de Corée)
(74) Agent: GOWLING WLG (CANADA) LLP
(74) Co-agent:
(45) Délivré:
(86) Date de dépôt PCT: 2013-07-12
(87) Mise à la disponibilité du public: 2014-01-23
Requête d'examen: 2019-07-04
Licence disponible: S.O.
Cédé au domaine public: S.O.
(25) Langue des documents déposés: Anglais

Traité de coopération en matière de brevets (PCT): Oui
(86) Numéro de la demande PCT: PCT/KR2013/006270
(87) Numéro de publication internationale PCT: KR2013006270
(85) Entrée nationale: 2014-12-31

(30) Données de priorité de la demande:
Numéro de la demande Pays / territoire Date
10-2012-0078921 (Republique de Corée) 2012-07-19

Abrégés

Abrégé français

La présente invention concerne un dispositif de buse et un dispositif d'injection minimalement invasif. Selon un mode de réalisation de la présente invention, le dispositif de buse pour un dispositif d'injection minimalement invasif comprend : une sortie pour former un micro-jet de liquide ; et une partie d'injection très petite reliée à la sortie et introduite dans le tissu de peau à une profondeur prédéterminée.


Abrégé anglais

The present invention relates to a nozzle device and a minimally invasive injection device. According to one embodiment of the present invention, the nozzle device for a minimally invasive injection device comprises: an outlet for forming a micro-jet of liquid; and a micro-sized injection portion connected to the outlet and inserted into the skin tissue at a predetermined depth.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.


WHAT IS CLAIMED IS:
1. A nozzle device for a minimally invasive injection device, comprising:
an outlet to generate a microjet of a liquid; and
an injection part of a micro-scale size connected to the outlet and adapted to
be inserted into a skin tissue to a preset depth.
2. The nozzle device for a minimally invasive injection device according
to claim 1, wherein the outlet is detachably connected to a first reservoir
part
containing the liquid to be injected.
3. The nozzle device for a minimally invasive injection device according
to claim 2, wherein the outlet and the first reservoir part have locking
structures,
respectively, to be locking-engaged with each other.
4. The nozzle device for a minimally invasive injection device according
to claim 1, wherein a minimum diameter of the outlet is less than or equal to
0.5 mm.
5. The nozzle device for a minimally invasive injection device according
to claim 1, wherein an inner diameter of the injection part is from 50 to 450
pm.
6. The nozzle device for a minimally invasive injection device according
to claim 1, wherein the injection part is inserted into the skin issue to the
depth
between 0.1 and 20 mm.
28

7. A minimally invasive injection device, comprising:
a nozzle part comprising a first reservoir part to contain a liquid to be
injected,
an outlet to generate a microjet of the liquid, and an injection part of a
micro-scale
size connected to the outlet and adapted to be inserted into a skin tissue to
a preset
depth; and
a pressure providing part comprising a first pressure applying part connected
to the first reservoir part and configured to apply pressure to the liquid,
and a first
pressure generator to provide the pressure to the first pressure applying
part.
8. The minimally invasive injection device according to claim 7, further
comprising:
a liquid providing part of manual or automated type connected to the first
reservoir part and configured to provide the liquid of a preset amount.
9. The minimally invasive injection device according to claim 7, wherein
the outlet is detachably connected to the first reservoir part containing the
liquid to be
injected.
10. The minimally invasive injection device according to claim 9, wherein
the outlet and the first reservoir part have locking structures, respectively,
to be
locking-engaged with each other.
11. The minimally invasive injection device according to claim 7, wherein
a single dose ejectable from the first reservoir part is from 1 to 1000 µl.
29

12. The minimally invasive injection device according to claim 8, wherein
the liquid providing part of automated type comprises a second reservoir part
to store
the liquid to be injected, a second pressure applying part to apply pressure
to the
second reservoir part, and a second pressure generator to provide the pressure
to
the second pressure applying part.
13. The minimally invasive injection device according to claim 12, further
comprising:
a controller connected to the second pressure generator and configured to
control a movement distance of the second pressure generator.
14. The minimally invasive injection device according to claim 7, further
comprising:
a third pressure applying part connected to the first pressure applying part
and configured to apply the pressure to the first reservoir part.
15. The minimally invasive injection device according to claim 7, further
comprising:
a controller connected to the first pressure generator and configured to
control at least one of a magnitude and a generation time of the pressure
generated
by the first pressure generator.
16. The minimally invasive injection device according to claim 15,
wherein the controller is connected to the first pressure generator and
configured to
control an extended distance or a retracted distance of the first pressure
applying

part.
17. The minimally invasive injection device according to claim 15,
wherein the controller is connected to the first pressure generator and
configured to
control to continuously move the first pressure applying part forward or
repeatedly
move the first pressure applying part forward and backward.
18. The minimally invasive injection device according to claim 7, wherein
a jet force of the microject being jet is adjusted by adjusting a diameter of
the outlet.
19. The minimally invasive injection device according to claim 7, wherein
a minimum diameter of the outlet is less than or equal to 0.5 mm.
20. The minimally invasive injection device according to claim 7, wherein
an inner diameter of the injection part is from 50 to 450 µm.
21. The minimally invasive injection device according to claim 7, wherein
the injection part is inserted into the skin issue to the depth between 0.1
and 20 mm.
22. The minimally invasive injection device according to claim 12,
wherein the first pressure generator or the second pressure generator includes
at
least one of the group consisting of a compression spring, compressed gas, an
explosive chemical substance, piezoelectricity, an electric driving motor, a
linear
Lorentz's force driving motor, an electric cylinder, and a linear motion
guide.
31

23. The minimally invasive injection device according to claim 12,
wherein the first pressure generator and the second pressure generator are an
integral pressure generator connected to the first pressure applying part and
the
second pressure applying part.
24. The minimally invasive injection device according to claim 7, wherein
a plurality of outlets and injection parts connected to the outlets are
connected to the
first reservoir part, and an area in which the plurality of outlets and
injection parts
connected to the outlets are placed is adjusted to adjust an ejection area of
the
microjet.
25. The minimally invasive injection device according to claim 12,
wherein the first pressure generator or the second pressure generator is
adapted to
generate the pressure from 1 to 100 bar.
26. The minimally invasive injection device according to claim 7, wherein
the liquid includes at least one selected from the group consisting of
hyaluronic acid,
collagen, a stem cell, a stem cell culture fluid, a fat cell, fat, silicon,
vitamin, a
placenta extract, blood plasma, tranexamic acid, a saline solution, polyvinyl
alcohol,
poly(methyl methacrylate), polyethylene glycol, cross-linked hyaluronic acid,
calcium
hydroxy apatide, polylactic acid, poly(lactic-co-glycolic acid),
pteroylglutamic acid,
poly-gamma-glutamic acid, phospholipid, deoxycholic acid, minoxidil,
finasteride,
dutasteride, a growth factor, botulinum toxin, alginic acid, chitosan,
chondroitin
sulfate, dermatan sulfate, hyaluronate lyase, an antibody, a pain relief
ingredient, and
an anesthetic ingredient.
32

27. The
minimally invasive injection device according to claim 7, wherein
the liquid is provided as at least one of a solution, a suspension, and a
dispersion in
which particles including active ingredients are dispersed.
33

Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


CA 02878256 2014-12-31
[DESCRIPTION]
[Invention Title]
NOZZLE DEVICE AND MINIMALLY INVASIVE INJECTION DEVICE
COMPRISING SAME
[Technical Field]
The present disclosure relates to a nozzle device and a minimally invasive
injection device, and more particularly, to a nozzle device that may minimize
pain
and bleeding from a skin while minimizing an injection loss of a liquid and a
minimally invasive injection device.
[Background Art]
In medical and cosmetic procedures, there is a need to inject a liquid under
the surface of the skin. For example, injecting insulin under the surface of
the skin
or injecting a substance such as collagen under the surface of the skin for
cosmetic
purposes is the case.
A most common method for injecting a liquid includes inserting an injection
needle into a desired part to a desired depth. However, when an injection
needle is
used, pain and bleeding are involved, and an injection needle may be inserted
improperly or wrongly based on a skill level of a user. Also, in the event of
improper
insertion into the skin, severe damage may occur to a skin tissue and the
damaged
skin needs treatment for a considerable period of time.
Accordingly, to solve the problem, a needle-free syringe has been recently
developed. Examples of a needle-free syringe include US Patent No. 8,066,662,
US Patent No. 7,942,845, Korean Patent No. 10-1062022, W02010/067345, and
W02010/016049.
1

CA 02878256 2014-12-31
A needle-free syringe does not have an injection needle, and instead, ejects
a liquid in the form of a high pressure microjet to allow the liquid to
permeate into the
skin in the form of the microjet. However, in the case of this syringe, to
allow the
microjet to penetrate and permeate into the skin to a desired depth,
sufficient
pressure and velocity needs to be guaranteed, and the microjet permeated into
the
skin needs to be immediately diffused into the tissue. However, the skin
varies, for
each layer, particularly, the stratum corneum and the epidermis, in thickness,
elasticity, flexibility and hardness, and even in the same individual, varies
in each
part.
Thus, a needle-free syringe is very difficult to uniformly permeate a liquid,
and because while permeating, an angle and a distance between a skin surface
and
an orifice from which a microjet is ejected and properties of a medicinal
fluid to be
permeated have a significant influence on an amount and a depth being
permeated,
controlling a loss and a permeation depth during injection of the medicinal
fluid is
difficult. Particularly, when a medicinal fluid of high viscosity is to be
delivered,
phenomena occurs in which a microjet of sufficient velocity is not generated
and
some of the permeated microjet is not diffused into the skin and comes out of
the
skin and collides backwards with a subsequent microjet emitted from an
orifice,
thereby further reducing the microjet velocity, resulting in further reduction
in skin
permeation capability.
[Summary of Invention]
[Technical Problem]
To address the above issues, the present disclosure is directed to providing a
minimally invasive injection device which may minimize an injection loss ratio
of a
microjet while minimizing pain and bleeding from a skin when permeated into
the
2

CA 02878256 2014-12-31
skin.
Also, the present disclosure is directed to providing a minimally invasive
injection device which may uniformly deliver a liquid without a loss,
independent of
properties of the liquid and characteristics of a target skin.
[Technical Solution]
A nozzle device for a minimally invasive injection device according to an
exemplary embodiment of the present disclosure includes an outlet to generate
a
microjet of a liquid, and an injection part of a micro-scale size connected to
the outlet
and adapted to be inserted into a skin tissue to a preset depth.
The outlet may be detachably connected to a first reservoir part containing
the liquid to be injected.
The outlet and the first reservoir part may have locking structures,
respectively, to be locking-engaged with each other.
A minimum diameter of the outlet may be less than or equal to 0.5 mm.
An inner diameter of the injection part may be from 50 to 450 pm.
The injection part may be inserted into the skin issue to the depth between
0.1 and 20 mm.
A minimally invasive injection device according to an exemplary embodiment
of the present disclosure includes a nozzle part including a first reservoir
part to
contain a liquid to be injected, an outlet to generate a microjet of the
liquid, and an
injection part of a micro-scale size connected to the outlet and adapted to be
inserted into a skin tissue to a preset depth, and a pressure providing part
including
a first pressure applying part connected to the first reservoir part and
configured to
apply pressure to the liquid, and a first pressure generator to provide the
pressure to
the first pressure applying part.
3

CA 02878256 2014-12-31
The minimally invasive injection device may further include a liquid providing
part of manual or automated type connected to the first reservoir part and
configured
to provide the liquid of a preset amount.
The outlet may be detachably connected to the first reservoir part containing
the liquid to be injected.
The outlet and the first reservoir part may have locking structures,
respectively, to be locking-engaged with each other.
A single dose ejectable from the first reservoir part may be from 1 to 1000
,uf
The liquid providing part of automated type may include a second reservoir
part to store the liquid to be injected, a second pressure applying part to
apply
pressure to the second reservoir part, and a second pressure generator to
provide
the pressure to the second pressure applying part.
The minimally invasive injection device may further include a controller
connected to the second pressure generator and configured to control a
movement
distance of the second pressure generator.
The minimally invasive injection device may further include a third pressure
applying part connected to the first pressure applying part and configured to
apply
the pressure to the first reservoir part.
The minimally invasive injection device may further include a controller
connected to the first pressure generator and configured to control at least
one of a
magnitude and a generation time of the pressure generated by the first
pressure
generator.
The controller may be connected to the first pressure generator and
configured to control an extended distance or a retracted distance of the
first
pressure applying part.
4

CA 02878256 2014-12-31
The controller may be connected to the first pressure generator and
configured to control to continuously move the first pressure applying part
forward or
repeatedly move the first pressure applying part forward and backward.
A jet force of the microject being jet may be adjusted by adjusting a diameter
of the outlet.
A minimum diameter of the outlet may be less than or equal to 0.5 mm.
An inner diameter of the injection part may be from 50 to 450 pm.
The injection part may be inserted into the skin issue to the depth between
0.1 and 20 mm.
The first pressure generator or the second pressure generator may be any
one of the group consisting of a compression spring, compressed gas, an
explosive
chemical substance, piezoelectricity, an electric driving motor, a linear
Lorentz's force
driving motor, an electric cylinder, and a linear motion guide.
The first pressure generator and the second pressure generator may be an
integral pressure generator connected to the first pressure applying part and
the
second pressure applying part.
A plurality of outlets and injection parts connected to the outlets may be
connected to the first reservoir part, and an area in which the plurality of
outlets and
injection parts connected to the outlets are placed may be adjusted to adjust
an
ejection area of the microjet.
The first pressure generator or the second pressure generator may be
adapted to generate the pressure from 1 to 100 bar.
The liquid may include at least one selected from the group consisting of
hyaluronic acid, collagen, a stem cell, a stem cell culture fluid, a fat cell,
fat, silicon,
vitamin, a placenta extract, blood plasma, tranexamic acid, a saline solution,
5

CA 02878256 2014-12-31
polyvinyl alcohol, poly(methyl methacrylate), polyethylene glycol, cross-
linked
hyaluronic acid, calcium hydroxy apatide, polylactic acid, poly(lactic-co-
glycolic acid),
pteroylglutamic acid, poly-gamma-glutamic acid, phospholipid, deoxycholic
acid,
minoxidil, finasteride, dutasteride, a growth factor, botulinum toxin, alginic
acid,
chitosan, chondroitin sulfate, dermatan sulfate, hyaluronate lyase, an
antibody, a
pain relief ingredient, and an anesthetic ingredient.
The liquid may be provided as at least one of a solution, a suspension, and a
dispersion in which particles including active ingredients are dispersed.
[Advantageous Effects]
According to an exemplary embodiment of the present disclosure, there is
provided a minimally invasive injection device that may mitigate discomfort of
a
patient caused by pain and bleeding while minimizing an injection loss ratio
under a
skin when a microjet is permeated into the skin.
Also, there is provided a minimally invasive injection device that may deliver
a uniform amount of liquid to a uniform depth independent of skin
characteristics of
an individual when injecting a liquid including active ingredients of various
properties.
Also, there is provided a minimally invasive injection device that may allow
continuous injection to increase an injection area for one-time injection or
perform
procedures on many objects.
[Description of Drawings]
FIG. 1 is a schematic diagram illustrating a minimally invasive injection
device
according to an exemplary embodiment of the present disclosure.
FIG. 2 is a schematic diagram illustrating a minimally invasive injection
device
according to a second exemplary embodiment of the present disclosure.
FIGS. 3A through 3C are partially enlarged views illustrating various
6

CA 02878256 2014-12-31
exemplary embodiments of section A of FIG. 2.
FIG. 4 is a schematic diagram illustrating a minimally invasive injection
device
according to a third exemplary embodiment of the present disclosure.
FIG. 5 is a cross-sectional view illustrating a minimally invasive injection
device according to a fourth exemplary embodiment of the present disclosure.
FIG. 6 is a perspective view illustrating a minimally invasive injection
device
according to a fifth exemplary embodiment of the present disclosure.
[Best Mode]
Hereinafter, a detailed description of a minimally invasive injection device
according to various exemplary embodiments of the present disclosure is
provided
with reference to FIGS. 1 through 6.
FIG. 1 is a schematic diagram illustrating a minimally invasive injection
device
according to an exemplary embodiment of the present disclosure.
Referring to FIG. 1, the minimally invasive injection device 1 according to an
exemplary embodiment of the present disclosure includes a nozzle part 10
(hereinafter, also referred to as a 'nozzle device') and a pressure providing
part 20.
The nozzle part 10 according to an exemplary embodiment of the present
disclosure includes an outlet 13 to generate a microjet, and an injection part
15 of a
micro-scale size connected to the outlet 13 and adapted to be inserted into a
skin
tissue to a preset depth.
The outlet 13, or an orifice may be adapted to have a desired size in
diameter to generate a microjet of a desired liquid.
According to an exemplary embodiment of the present disclosure, a jet force
of the microjet may be adjusted by adjusting the diameter of the outlet 13.
Because
the diameter of the outlet 13 is inversely proportional to the jet force of
the microjet,
7

CA 02878256 2014-12-31
the jet force of the microjet may be adjusted by adjusting the diameter of the
outlet
13 based on a part and a property of a target skin or tissue.
According to an exemplary embodiment of the present disclosure, a minimum
diameter of the outlet 13 may be less than or equal to 0.5 mm. Particularly,
the
minimum diameter of the outlet 13 may be less than or equal to 0.3 mm,
preferably,
0.2 mm. This is to permeate the liquid into a desired skin tissue quickly
under
pressure within the nozzle part 10.
According to an exemplary embodiment of the present disclosure, an area
being jetted may be adjusted. More specifically, an injection area may be
adjusted
by placing a plurality of injection parts 15 within a preset area to adjust
the injection
area of the microjet. When one injection needle is used according to a related
art, a
liquid is injected into only one spot with one-time injection, but when the
nozzle part
according to an exemplary embodiment of the present disclosure is used,
because
the plurality of injection parts 15 is placed over a predetermined area, a
liquid may be
injected into a plurality of spots over a desired area of a skin of an object.
Thus, the
minimally invasive injection device may inject a liquid with one-time
injection over a
desired area with no need to inject multiple times.
The injection part 15 is configured to inject a liquid filled in a first
reservoir
part 11 into a target skin tissue. The microjet emitted through the outlet 13
may be
guided to a preset skin depth by the desired injection part 15. According to
an
exemplary embodiment of the present disclosure, a needle of a micro-scale size
may
be used as the injection part 15.
According to an exemplary embodiment of the present disclosure, before
injection, the injection part 15 may come into contact with the skin,
penetrate through
the stratum corneum or the epidermis, and be located on the dermis. Then, a
high
8

CA 02878256 2014-12-31
speed and high pressure microjet may be ejected into and below the dermis at a
high speed, penetrate into a target part, and be diffused and absorbed into a
surrounding tissue.
In the case of a traditional needle-free device, because a microjet enters the
stratum corneum or the epidermis directly, the microjet does not permeate into
and
below the dermis. Moreover, the presence of a microject not penetrating the
stratum corneum or the epidermis and coming out of them reduces efficiency of
a
minimally invasive injection device.
However, according to an exemplary
embodiment of the present disclosure, because the injection part 15 guides the
microjet to the stratum corneum or the epidermis, the microjet may go through
the
stratum corneum or the epidermis safely and be injected to a desired depth.
Particularly, the stratum corneum and the epidermis differ in thickness and
hardness
for each individual and for each part of an individual, but according to an
exemplary
embodiment of the present disclosure, because the microjet is guided to the
stratum
corneum and the epidermis by the injection part 15, the microjet may be
injected into
and below the dermis in a simple manner without a separate operation of
adjusting
the velocity and pressure of the microjet.
Also, when a traditional syringe is used, it is difficult to adjust an
insertion
depth of a needle, and due to a hole created in the skin by the needle, an
object
feels pain and in some instances, bleeds, and a liquid flows out through the
needle
hole created in the skin, leading to a liquid loss, but according to an
exemplary
embodiment of the present disclosure, the injection part 15 penetrates the
skin to a
minimum extent, and thus, an object scarcely suffers from bleeding and pain
and a
liquid loss caused by a liquid outflow is prevented.
An insertion depth of the injection part 15 according to an exemplary
9

CA 02878256 2014-12-31
embodiment of the present disclosure may be from 0.1 to 20 mm. When the
insertion depth is less than 0.1 mm, it is difficult to guide through the
stratum
corneum or the epidermis, and when the insertion depth exceeds 20 mm, an
object
may feel pain.
Preferably, based on a location and a skin thickness of a target part, the
insertion depth of the injection part 15 may be from 0.5 to 10 mm and from 0.2
to 5
mm.
According to an exemplary embodiment of the present disclosure, an inner
diameter of the injection part 15 may be from 50 to 450 pm. When the inner
diameter is less than 50 pm, it is difficult to generate a microjet, and when
the inner
diameter exceeds 450 pm, a liquid may come out or bleeding may occur.
Preferably, the inner diameter of the injection part 15 may be from 50 to 410
pm, from 50 to 220 pm, and from 50 to 170 pm, based on properties of a target
liquid
such as viscosity or a target part.
According to an exemplary embodiment of the present disclosure, the nozzle
part 10 may further include the first reservoir part 11 to store a liquid
corresponding
to a single dose. Also, the first reservoir part 11 may be constructed as a
syringe or
its similar form of housing, and may be configured to store an amount of
liquid
corresponding to an intended number of injections.
The first reservoir part 11 may be connected to a liquid providing part which
provides a liquid. According to an exemplary embodiment of the present
disclosure,
the first reservoir part 11 may be integrally formed with the liquid providing
part so
that a single dose or more of liquid may be stored in the first reservoir part
11 and
ejected one or more times. However, the present disclosure is not necessarily
limited thereto, and according to another exemplary embodiment of the present

CA 02878256 2014-12-31
disclosure, a separate liquid providing part of manual or automated type which
provides a preset amount of liquid, for example, a liquid corresponding to a
single
dose, may be included.
According to an exemplary embodiment of the present disclosure, a single
dose injectable through the first reservoir part 11 may be from 1 to 1000 fzi.
The
present disclosure is not necessarily limited thereto, and it is obvious that
the single
dose may be variously selected as desired.
Referring to FIG. 1, the outlet 13 may be detachably connected to the first
reservoir part 11 containing the liquid to be injected.
The outlet 13 may include a first connecting part 12 which is connected to the
first reservoir part 11, and the first connecting part 12 may have a locking
structure
12a for locking engagement with the first reservoir part. Also, the first
reservoir part
11 may include a second connecting part 14 which is connected to the outlet
13, and
the second connecting part 14 may have a locking structure 14a for locking
engagement with the outlet 13.
As the first connecting part 12 and the second connecting part 14 have the
locking structures 12a and 14a shaped of screw threads to be engaged with each
other, respectively, the outlet 13 and the first reservoir part 11 may be
thread
engaged.
Thus, a needle part X including the outlet 13 and the injection part 15 may be
detachably connected to the first reservoir part 11, and by coupling the
outlet 13 and
the injection part 15 to the first reservoir part 11, the nozzle part 10 may
be
constructed.
Accordingly, because a user needs to replace only the needle part X in the
nozzle part 10, the user may reduce efforts to change the injection device
each time
11

CA 02878256 2014-12-31
an object is changed and save the maintenance and replacement costs. Also, the
user may use the injection device more sanitarily by replacing the needle part
X as
needed.
According to an exemplary embodiment of the present disclosure, a third
pressure applying part 19 which applies the pressure to the first reservoir
part 11
may be further included. The third pressure applying part 19 may be, but not
necessarily limited to, a plunger.
The third pressure applying part 19 is connected to the pressure providing
part 20, to be concrete, a first pressure applying part 21, and is configured
to
transmit the pressure provided by the pressure providing part 20 to the first
reservoir
part 11.
The pressure providing part 20 is configured to provide the pressure to allow
the nozzle part 10 to generate a microjet. The pressure providing part 20
includes
the first pressure applying part 21 and a first pressure generator 23.
The first pressure applying part 21 may be a piston adapted to make a linear
motion within the pressure providing part 20 or a housing of the minimally
invasive
injection device.
The first pressure generator 23 corresponds to a device for providing the
pressure to the first pressure applying part 21, and may be configured to
provide the
pressure by various methods in the art, for example, a motor type, an air
pressure
type, or a gas emission type.
The first pressure generator 23 may be placed in one housing together with
the first pressure applying part 21, but the present disclosure is not
necessarily
limited thereto, and the first pressure generator 23 may be placed outside of
a
housing in which the first pressure applying part 21 is placed, within the
range of
12

CA 02878256 2014-12-31
providing the pressure to the first pressure applying part 21.
The first pressure generator 23 enables the first pressure applying part 21 to
make an instantaneous high-speed linear motion, and when the first pressure
applying part 21 moves forward instantaneously at a high speed within the
pressure
providing part 20, the pressure may be applied to the liquid present in the
first
reservoir part 11 of the nozzle part 10 directly through the first pressure
applying part
21 or indirectly through the third pressure applying part 19.
According to an exemplary embodiment of the present disclosure, the first
pressure generator 23 may further include a controller (not shown) to control
at least
one of a magnitude and a generation time of the pressure generated by the
first
pressure generator 23. That is, the controller is configured to allow a user
to adjust
an amount of energy generated by the first pressure generator 23 through the
controller, and particularly, the controller is configured to adjust a
permeation depth
of the microjet, for example, to a depth sufficient for the microjet to
permeate into
and below the dermis by adjusting the strength of the pressure, and adjust a
jet
amount by adjusting the pressure generation time.
According to an exemplary embodiment of the present disclosure, it is
obvious that a transparent window through which a storage amount of the first
reservoir part 11 is seen may be configured to observe an amount of liquid
being
injected.
The third pressure applying part 19 may be located in a retracted position at
a liquid filling location, and in an extended position at a liquid ejection
location. A
one-time extended distance is proportional to a single dose. Thus, according
to an
exemplary embodiment of the present disclosure, the controller (not shown) may
be
configured to adjust a single dose by adjusting the pressure generated by the
13

CA 02878256 2014-12-31
pressure providing part 20 to adjust a one-time extended distance.
According to an exemplary embodiment of the present disclosure, the first
pressure generator 23 may include, but not necessarily limited to, any one of
the
group consisting of a compression spring, compressed gas, an explosive
chemical
substance, piezoelectricity, an electric driving motor, a linear Lorentz's
force driving
motor, an electric cylinder, and a linear motion guide, and various pressure
generators in the art may be applied.
FIG. 2 is a schematic diagram illustrating a minimally invasive injection
device
according to a second embodiment of the present disclosure. FIG. 3A is a
partially
enlarged view of section A of FIG. 2 illustrating a state that a liquid is
filled in a nozzle
part 100, FIG. 3B is a partially enlarged view of section A of FIG. 2
illustrating a state
that the liquid is ejected from the nozzle part 100, and FIG. 3C is a
partially enlarged
view of the nozzle part 100 according to another exemplary embodiment of the
present disclosure.
Referring to FIGS. 2 and 3A, the minimally invasive injection device 2
according to the second exemplary embodiment of the present disclosure
provides
the nozzle part 100 and a pressure providing part 200 integrally formed.
In the minimally invasive injection device according to an exemplary
embodiment of the present disclosure, the nozzle part 100 includes a first
reservoir
part 101 in which a liquid to be injected is received, an outlet 103 of a
micro-scale
size to generate a microjet of the liquid, and an injection part 105 of a
micro-scale
size connected to the outlet 103 and adapted to be inserted into a skin tissue
to a
preset depth, and the pressure providing part 200 includes a first pressure
applying
part 201 connected to the first reservoir part 101 and configured to apply
pressure to
the liquid, and a first pressure generator 203 to provide the pressure to the
first
14

CA 02878256 2014-12-31
pressure applying part 201.
The nozzle part 100 is configured to eject a microjet injectable into the
skin,
and includes the first reservoir part 101, the outlet 103, and the injection
part 105.
Also, according to another exemplary embodiment of the present disclosure, a
third
pressure applying part 109 which applies the pressure to the first reservoir
part 101
may be further included.
According to an exemplary embodiment of the present disclosure, the first
reservoir part 101 is configured to store a liquid corresponding to a single
dose.
The first reservoir part 101 may be connected to a liquid providing part which
provides a liquid through a first provision connecting part 107. According to
an
exemplary embodiment of the present disclosure, a liquid providing part of
manual or
automated type which provides a preset amount of liquid, for example, a liquid
corresponding to a single dose, may be further included. The present
disclosure is
not necessarily limited thereto, and similar to the previous embodiment, the
liquid
providing part may be integrally formed with the first reservoir part 101.
According to an exemplary embodiment of the present disclosure, a single
dose injectable through the first reservoir part 101 may be from 1 to 1000 0.
The
present disclosure is not necessarily limited thereto, and it is obvious that
the single
dose may be variously selected as desired.
Referring to FIG. 3B, the outlet 103, or orifice may be adapted to have a
desired size in diameter to generate a microjet of a desired liquid.
According to an exemplary embodiment of the present disclosure, a jet force
of the microjet may be adjusted by adjusting the diameter of the outlet 103.
Because the diameter of the outlet 103 is inversely proportional to the jet
force of the
microjet, the jet force of the microjet may be adjusted by adjusting the
diameter of

CA 02878256 2014-12-31
the outlet 103 based on a part and a property of a target skin or tissue.
According to an exemplary embodiment of the present disclosure, a minimum
diameter (ti) of the outlet 103 may be less than or equal to 0.5 mm. When the
minimum diameter (t1) of the outlet 103 exceeds 0.5 mm, a high speed and high
pressure microjet is not generated and is difficult to permeate into a skin to
a desired
depth.
Also, the minimum diameter (t1) of the outlet 103 may be less than or equal
to 0.3 mm, and preferably, may be less than or equal to 0.2 mm. This is to
permeate the liquid into a desired skin tissue quickly under pressure within
the
nozzle part 100.
According to an exemplary embodiment of the present disclosure, an area
being jetted may be adjusted. By placing a plurality of outlets 103 and
injection
parts 105 within an area of a microject of a desired area, it is possible to
inject the
liquid at a plurality of spots over a wide area rather than one spot on the
skin. Thus,
according to an exemplary embodiment of the present disclosure, a desired
liquid
may be injected into a wide area through a single injection, but not multiple
injections.
The injection part 105 is configured to inject the liquid filled in the first
reservoir part 101 into a target skin tissue. The microjet ejected through the
outlet
103 may be guided to a preset skin depth by the desired injection part 105.
According to an exemplary embodiment of the present disclosure, a needle of a
micro-scale size may be used as the injection part 105.
According to an exemplary embodiment of the present disclosure, before
injection, the injection part 105 may come into contact with the skin,
penetrate
through the stratum corneum or the epidermis, and be located on the dermis.
Also,
a high speed and high pressure microjet may be ejected into and below the
dermis
16

CA 02878256 2014-12-31
at a high speed, penetrate into a target part, and be diffused and absorbed
into a
surrounding tissue.
Referring to FIG. 3B, an insertion depth (t2) of the injection part 105
according
to an exemplary embodiment of the present disclosure may be from 0.1 to 20 mm.
When the insertion depth is less than 0.1 mm, it is difficult to guide through
the
stratum corneum or the epidermis, and when the insertion depth exceeds 20 mm,
an
object may feel pain.
Preferably, based on a location and a skin thickness of a target part, the
insertion depth (t2) of the injection part 105 may be from 0.5 to 10 mm and
from 0.2
to 5 mm.
According to an exemplary embodiment of the present disclosure, an inner
diameter (t3) of the injection part 105 may be from 50 to 450 pm. When the
inner
diameter is less than 50 pm, it is difficult to generate a microjet, and when
the inner
diameter exceeds 450 pm, a liquid may come out or bleeding may occur.
Preferably, the inner diameter (t3) of the injection part 105 may be from 50
to
410 pm, from 50 to 220 pm, and from 50 to 170 pm, based on properties of a
target
liquid such as viscosity or a target part.
Referring to FIGS. 3A and 3B, according to an exemplary embodiment of the
present disclosure, a third pressure applying part 109 which applies the
pressure to
the first reservoir part may be further included. The third pressure applying
part 109
may be, but not necessarily limited to, a plunger.
The third pressure applying part 109 is connected to the pressure providing
part 200, to be concrete, a first pressure applying part 201, and is
configured to
transmit the pressure provided by the pressure providing part 200 to the first
reservoir part 101.
17

CA 02878256 2014-12-31
The third pressure applying part 109 may be located at a retracted position in
a liquid filling state (see FIG. 3A), and at an extended position in a liquid
ejection
state (see FIG. 3B). Particularly, according to an exemplary embodiment of the
present disclosure, the third pressure applying part 109 may have a protrusion
108
corresponding to the outlet 103. The protrusion 108 may be respectively
inserted
into the outlet 103, thereby generating a high speed and high pressure
microjet more
efficiently.
Referring to FIG. 3A, to limit the extended distance of the first pressure
applying part 201 or the third pressure applying part 109, a ring 401 is
formed in the
first pressure applying part 201 and a groove 403 is formed in the first
reservoir part
101 at a location corresponding to the extended distance such that the groove
403
may be engaged with the ring 401, and by their coupling, the extended distance
may
be limited.
Also, referring to FIG. 3C, or a partially enlarged view of the nozzle part
100
according to another exemplary embodiment of the present disclosure, a locking
step 405 connected to a spring is formed on the third pressure applying part
109,
and the locking step 405 may be adapted to be engaged with a groove part 407
formed at a location corresponding to the extended distance or the first
provision
connecting part 107.
Referring to FIGS. 2 and 4, the pressure providing part 200 is configured to
provide the pressure to allow the nozzle part 100 to generate a microjet.
The pressure providing part 200 includes the first pressure applying part 201
and the first pressure generator 203.
The first pressure applying part 201 may be a piston adapted to make a
linear motion within the pressure providing part 200 or a housing of the
minimally
18

CA 02878256 2014-12-31
invasive injection device.
The first pressure generator 203 corresponds to a device for providing the
pressure to the first pressure applying part 201, and may be configured to
provide
the pressure by various methods in the art, for example, a motor type, an air
pressure type, or a gas emission type.
The first pressure generator 203 enables the first pressure applying part 201
to make an instantaneous high-speed linear motion, and when the first pressure
applying part 201 moves forward instantaneously at a high speed within the
pressure
providing part 200, the pressure may be applied to the liquid present in the
first
reservoir part 101 of the nozzle part 100 directly through the first pressure
applying
part 201 or indirectly through the third pressure applying part 109.
According to an exemplary embodiment of the present disclosure, the first
pressure generator 203 may further include a controller (not shown) to control
at
least one of a magnitude and a generation time of the pressure generated by
the first
pressure generator 203. That is, the controller is configured to allow a user
to
adjust an amount of energy generated by the first pressure generator 203
through
the controller, and particularly, the controller is configured to adjust a
permeation
depth of the microjet, for example, to a depth sufficient for the microjet to
permeate
into and below the dermis by adjusting the strength of the pressure, and
adjust a jet
amount by adjusting the pressure generation time.
According to another exemplary embodiment of the present disclosure, the
first pressure generator 203 may be configured to control the extended
distance or
the retracted distance of the first pressure applying part 201 by the
controller.
The extended distance of the first pressure applying part 201 corresponds to
a single dose, and the retracted distance of the first pressure applying part
201 is
19

CA 02878256 2014-12-31
proportional to an amount of liquid stored in the first reservoir part 101.
According to an exemplary embodiment of the present disclosure, the
amount of liquid stored in the first reservoir part 101 may be adjusted by
controlling
the retracted distance of the first pressure applying part 201. For example,
to store
a single dose in the first reservoir part 101, an amount of liquid
corresponding to a
single dose may be stored in the first reservoir part 101 by moving the first
pressure
applying part 201 backward.
To store a single dose of liquid in the first reservoir part 101, the liquid
may
be stored using a liquid providing part 300 of automated or manual type by
adjusting
the retracted distance of the first pressure applying part 201 or the third
pressure
applying part 109, or by adjusting the retracted distance of the first
pressure applying
part 201 through the controller in such a state that the first reservoir part
101 is
connected to a liquid supply source (not shown).
According to an exemplary embodiment of the present disclosure, it is
obvious that a transparent window through which a storage amount of the first
reservoir part 101 is seen may be configured to observe an amount of liquid
being
injected.
According to an exemplary embodiment of the present disclosure, the
controller may be connected to the first pressure generator 203 and configured
to
enable the first pressure applying part 201 to continuously move forward or
repeatedly move forward and backward.
That is, the microjet may be continuously ejected by a continuous forward
movement of the first pressure applying part 201, and when a single dose of
liquid is
stored in the first reservoir part 101, the microjet may be continuously
ejected
automatically by performing a one-time ejection and a one-time storage

CA 02878256 2014-12-31
automatically through continuous forward and backward movements of the first
pressure applying part 201, while being connected to the liquid supply source.
Thus, according to an exemplary embodiment of the present disclosure, the
minimally invasive injection device may continuously inject a liquid without
separately
performing inflow and ejection operations of the liquid. Accordingly, a user's
effort
to inject a liquid each time may reduce.
According to an exemplary embodiment of the present disclosure, the first
pressure generator may include, but not necessarily limited to, any one of the
group
consisting of a compression spring, compressed gas, an explosive chemical
substance, piezoelectricity, an electric driving motor, a linear Lorentz's
force driving
motor, an electric cylinder, and a linear motion guide, and various pressure
generators in the art may be applied.
According to an exemplary embodiment of the present disclosure, the first
pressure generator 203 may be configured to generate the pressure from 1 to
100
bar. When the pressure less than 1 bar is generated, it is difficult to
generate a
microjet, and when the pressure higher than 100 bar is generated, an unwanted
damage may occur to an object.
FIG. 4 is a cross-sectional view illustrating a minimally invasive injection
device 2 according to a third exemplary embodiment of the present disclosure,
including the nozzle part 100, the pressure providing part 200, and a liquid
providing
part 300.
According to an exemplary embodiment of the present disclosure, the nozzle
part 100 may be configured to provide the liquid to the first reservoir part
101 by
connecting a tube to the first provision connecting part 109 or directly
connecting to a
liquid supply source or the liquid providing part 300 of automated or manual
type.
21

CA 02878256 2014-12-31
According to an exemplary embodiment of the present disclosure, when the
liquid is provided while being connected to the liquid supply source as
described in
the foregoing, or a single dose or more is stored in the first reservoir part
101, the
liquid may be ejected by forward and backward movements of the first pressure
applying part 201 of the pressure providing part 200.
Also, when the liquid providing part of manual type is used, the liquid may be
provided to the first reservoir part 101 by connecting a device such as a
general
syringe including a piston to the first provision connecting part 107 directly
or
indirectly through a tube.
Also, according to the exemplary embodiment of FIG. 4, when the liquid
providing part 300 of automated type is used, the liquid providing part 300
may
include a second reservoir part 301 to store the liquid to be injected, a
second
pressure applying part 303 to apply the pressure to the second reservoir part
301,
and a second pressure generator 305 to provide the pressure to the second
pressure applying part.
According to an exemplary embodiment of the present disclosure, a second
provision connecting part 307 may be connected to the first provision
connecting part
107 by a tube 309, and the second reservoir part 301 serves to store the
liquid and
provide the liquid of a preset amount, for example, the liquid corresponding
to a
single dose to the first reservoir part 101.
The liquid providing part 300 may be provided with the second pressure
applying part 303 to apply the pressure to the second reservoir part 301, and
according to an exemplary embodiment of the present disclosure, the second
pressure applying part 303 may include a piston, or a flow rod connected to
the
piston to induce a linear motion of the piston.
22

CA 02878256 2014-12-31
Also, the liquid providing part 300 may include the second pressure
generator 305 to provide the pressure to the second pressure applying part 303
to
cause a linear motion. An amount of liquid being provided to the first
reservoir part
101 may be determined based on a movement distance of the second pressure
applying part 303 by the second pressure generator 305.
According to an exemplary embodiment of the present disclosure, a
controller (not shown) which is connected to the second pressure generator 305
and
configured to control a movement distance of the second pressure applying part
303
by the second pressure generator 305 to adjust a single dose may be further
included. The controller of the second pressure generator 305 may be the same
as
the controller of the first pressure generator 203, and the second pressure
generator
305 may be controlled by a separate controller.
The second pressure generator 305 may be any one of the group consisting
of a compression spring, compressed gas, an explosive chemical substance,
piezoelectricity, an electric driving motor, a linear Lorentz's force driving
motor, an
electric cylinder, and a linear motion guide, but the present disclosure is
not
necessarily limited thereto, and various pressure generators in the art may be
used.
According to an exemplary embodiment of the present disclosure, the second
pressure generator 305 may be configured to generate the pressure from 1 to
100
bar, but the present disclosure is not necessarily limited thereto.
According to an exemplary embodiment of the present disclosure, the first
pressure generator 203 and the second pressure generator 305 may be formed as
an integral pressure generator and connected to the first pressure applying
part 201
and the second pressure applying part 303, respectively, but the present
disclosure
is not necessarily limited thereto, and it is obvious that the first pressure
generator
23

CA 02878256 2014-12-31
203 and the second pressure generator 305 may be separately formed.
The liquid may include, but not necessarily limited to, at least one selected
from the group consisting of hyaluronic acid, collagen, a stem cell, a stem
cell culture
fluid, a fat cell, fat, silicon, vitamin, a placenta extract, blood plasma,
tranexamic acid,
a saline solution, polyvinyl alcohol, poly(methyl methacrylate), polyethylene
glycol,
cross-linked hyaluronic acid, calcium hydroxy apatide, polylactic acid (PLLA),
poly(lactic-co-glycolic acid) (PLGA), pteroylglutamic acid (PGA), poly-gamma-
glutamic acid, phospholipid, deoxycholic acid, minoxidil, finasteride,
dutasteride, a
growth factor, botulinum toxin, alginic acid, chitosan, chondroitin sulfate,
dermatan
sulfate, hyaluronate lyase, an antibody, a pain relief ingredient, and an
anesthetic
ingredient, and may include various substances used in the art.
The liquid may be provided in at least one type of a solution, a suspension,
and a dispersion in which particles including active ingredients are
dispersed, but the
present disclosure is not necessarily limited thereto, and the liquid may be
provided
in various states available in the art.
FIG. 5 is a cross-sectional view illustrating a minimally invasive injection
device 4 according to a fourth exemplary embodiment of the present disclosure.
Referring to FIG. 5, the minimally invasive injection device 4 includes the
nozzle part 100 and the pressure providing part 200.
The nozzle part 100 of the minimally invasive injection device 4 according to
the fourth exemplary embodiment of the present disclosure includes the first
reservoir part 101, the outlet 103, and the injection part 105 connected to
the outlet
103, and the third pressure applying part 109 is provided in the first
reservoir part
101 to apply pressure to the first reservoir part 101. Also, the first
reservoir part 101
is equipped with the first provision connecting part 107 to provide a liquid
using a
24

CA 02878256 2014-12-31
liquid supply source or a pressure providing part of manual or automated type.
The pressure providing part 200 includes a first pressure applying part which
makes a linear motion and is connected to the third pressure applying part
109.
The first pressure applying part may be constructed as a series of connecting
rods
211a and 211b to transmit the pressure to the third pressure applying part
109.
The connecting rods 211a and 211b according to the fourth exemplary
embodiment of the present disclosure are connected to a first pressure
generator
(not shown) and adapted to make a linear reciprocating motion, and
specifically, the
first pressure generator (not shown) may be configured to allow air inflow or
outflow
to two air providing parts 213a and 213b to move the connecting rods 211a and
211b
forward at a high speed.
FIG. 6 is a perspective view illustrating a minimally invasive injection
device 5
according to a fifth exemplary embodiment of the present disclosure.
Referring to FIG. 6, the minimally invasive injection device 5 according to
the
fifth exemplary embodiment of the present disclosure includes the nozzle part
100,
the pressure providing part 200, and the liquid providing part 300. According
to the
fifth exemplary embodiment of the present disclosure, the nozzle part 100, the
pressure providing part 200, and the liquid providing part 300 are provided as
mounted in a housing, and the integral minimally invasive injection device 5
may
provide convenience in portability and manipulation to a user.
The nozzle part 100 of the minimally invasive injection device 5 according to
the fifth exemplary embodiment of the present disclosure includes the first
reservoir
part, the outlet, and the injection part 105 connected to the outlet, and the
third
pressure applying part is provided in the first reservoir part to apply
pressure to the
first reservoir part. Also, the first reservoir part may be equipped with the
first

CA 02878256 2014-12-31
provision connecting part 107 connected to the second provision connecting
part 307
to receive a liquid from the liquid providing part 300 of automated type.
The pressure providing part 200 may be configured to provide pressure to
the nozzle part 100 to thus eject a microjet from the nozzle part 100.
According to
an exemplary embodiment of the present disclosure, because the plurality of
injection parts 105 and outlets 103 are provided within a preset area, a
plurality of
microjets may be generated within a desired area at once, and consequently,
the
liquid may be ejected within the desired area at once.
Also, the nozzle part 100 may be connected to the liquid providing part 300 of
automated type, and the liquid providing part 300 may include a second
reservoir
part 311 and a second pressure applying part including a series of flow rods
313a
and 313b which applies pressure to the second reservoir part 311. Also, the
second
pressure applying part may be connected to a second pressure generator (not
shown) which operates by various mechanisms such as a motor type or a
hydraulic
type to provide pressure causing a linear reciprocating motion.
According to an exemplary embodiment of the present disclosure, there is
provided a minimally invasive injection device which may perform supply and
injection of a liquid by a series of automated operations and stably provide a
liquid to
a target location below the epidermis.
According to an exemplary embodiment of the present disclosure, there is
provided a minimally invasive injection device which may inject a liquid to a
desired
target depth independent of properties of an active substance to be
administered,
that is, the liquid. Particularly, in the case of a high viscosity liquid,
phenomena
occurs in which the liquid does not penetrate the stratum corneum or the
epidermis
of the skin due to the high viscosity or a jet of sufficient velocity is not
generated and
26

CA 02878256 2014-12-31
the jet is not diffused into the skin quickly and comes out of the skin, but
the
minimally invasive injection device of the present disclosure guides a
microjet to a
minimum depth using the injection part and ejects the microjet, and thus
allows an
active substance to be absorbed to a target depth without an outflow
phenomenon.
Also, according to an exemplary embodiment of the present disclosure, there
is provided a minimally invasive injection device which may minimize pain or
bleeding of an object, avoid creating a large needle hole and consequently
keep an
administered liquid from flowing back out, and prevent a liquid loss caused by
a
liquid oufflow, resulting in improved permeation capability and efficiency.
[Industrial Applicability]
There is provided a nozzle device which may alleviate discomfort of a patient
caused by pain and bleeding while minimizing an injection loss ratio under a
skin
when a microjet is permeated through the skin and a minimally invasive
injection
device. Also, there is provided a nozzle device which may deliver a uniform
amount
of liquid to a uniform depth independent of skin characteristics of an
individual when
injecting a liquid including active ingredients of various properties and a
minimally
invasive injection device.
27

Dessin représentatif
Une figure unique qui représente un dessin illustrant l'invention.
États administratifs

2024-08-01 : Dans le cadre de la transition vers les Brevets de nouvelle génération (BNG), la base de données sur les brevets canadiens (BDBC) contient désormais un Historique d'événement plus détaillé, qui reproduit le Journal des événements de notre nouvelle solution interne.

Veuillez noter que les événements débutant par « Inactive : » se réfèrent à des événements qui ne sont plus utilisés dans notre nouvelle solution interne.

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , Historique d'événement , Taxes périodiques et Historique des paiements devraient être consultées.

Historique d'événement

Description Date
Demande non rétablie avant l'échéance 2023-10-10
Inactive : Morte - Taxe finale impayée 2023-10-10
Lettre envoyée 2023-07-12
Réputée abandonnée - omission de répondre à un avis sur les taxes pour le maintien en état 2023-01-12
Réputée abandonnée - les conditions pour l'octroi - jugée non conforme 2022-10-07
Lettre envoyée 2022-07-12
Un avis d'acceptation est envoyé 2022-06-07
Lettre envoyée 2022-06-07
month 2022-06-07
Un avis d'acceptation est envoyé 2022-06-07
Inactive : Approuvée aux fins d'acceptation (AFA) 2022-04-25
Inactive : Q2 réussi 2022-04-25
Modification reçue - réponse à une demande de l'examinateur 2022-01-21
Modification reçue - modification volontaire 2022-01-21
Rapport d'examen 2021-09-22
Inactive : Rapport - Aucun CQ 2021-09-13
Modification reçue - réponse à une demande de l'examinateur 2021-06-04
Modification reçue - modification volontaire 2021-06-04
Demande visant la révocation de la nomination d'un agent 2021-03-19
Requête pour le changement d'adresse ou de mode de correspondance reçue 2021-03-19
Demande visant la nomination d'un agent 2021-03-19
Rapport d'examen 2021-02-09
Inactive : Rapport - CQ réussi 2021-02-04
Modification reçue - modification volontaire 2020-11-27
Représentant commun nommé 2020-11-07
Rapport d'examen 2020-07-29
Inactive : Rapport - Aucun CQ 2020-07-24
Représentant commun nommé 2019-10-30
Représentant commun nommé 2019-10-30
Lettre envoyée 2019-07-11
Lettre envoyée 2019-07-11
Toutes les exigences pour l'examen - jugée conforme 2019-07-04
Exigences de rétablissement - réputé conforme pour tous les motifs d'abandon 2019-07-04
Requête d'examen reçue 2019-07-04
Exigences pour une requête d'examen - jugée conforme 2019-07-04
Requête en rétablissement reçue 2019-07-04
Inactive : Abandon.-RE+surtaxe impayées-Corr envoyée 2018-07-12
Requête pour le changement d'adresse ou de mode de correspondance reçue 2018-01-16
Exigences relatives à la révocation de la nomination d'un agent - jugée conforme 2016-04-22
Inactive : Lettre officielle 2016-04-22
Exigences relatives à la nomination d'un agent - jugée conforme 2016-04-22
Demande visant la révocation de la nomination d'un agent 2016-03-30
Demande visant la nomination d'un agent 2016-03-30
Inactive : Page couverture publiée 2015-02-13
Inactive : CIB attribuée 2015-02-13
Inactive : CIB attribuée 2015-02-06
Inactive : CIB attribuée 2015-02-06
Inactive : CIB en 1re position 2015-02-06
Inactive : CIB enlevée 2015-02-06
Inactive : CIB en 1re position 2015-01-21
Inactive : Notice - Entrée phase nat. - Pas de RE 2015-01-21
Inactive : CIB attribuée 2015-01-21
Inactive : CIB attribuée 2015-01-21
Inactive : CIB attribuée 2015-01-21
Demande reçue - PCT 2015-01-21
Exigences pour l'entrée dans la phase nationale - jugée conforme 2014-12-31
Demande publiée (accessible au public) 2014-01-23

Historique d'abandonnement

Date d'abandonnement Raison Date de rétablissement
2023-01-12
2022-10-07
2019-07-04

Taxes périodiques

Le dernier paiement a été reçu le 2021-07-05

Avis : Si le paiement en totalité n'a pas été reçu au plus tard à la date indiquée, une taxe supplémentaire peut être imposée, soit une des taxes suivantes :

  • taxe de rétablissement ;
  • taxe pour paiement en souffrance ; ou
  • taxe additionnelle pour le renversement d'une péremption réputée.

Les taxes sur les brevets sont ajustées au 1er janvier de chaque année. Les montants ci-dessus sont les montants actuels s'ils sont reçus au plus tard le 31 décembre de l'année en cours.
Veuillez vous référer à la page web des taxes sur les brevets de l'OPIC pour voir tous les montants actuels des taxes.

Historique des taxes

Type de taxes Anniversaire Échéance Date payée
Taxe nationale de base - générale 2014-12-31
TM (demande, 2e anniv.) - générale 02 2015-07-13 2015-06-16
TM (demande, 3e anniv.) - générale 03 2016-07-12 2016-06-23
TM (demande, 4e anniv.) - générale 04 2017-07-12 2017-06-13
TM (demande, 5e anniv.) - générale 05 2018-07-12 2018-06-07
2019-07-04
Requête d'examen - générale 2019-07-04
TM (demande, 6e anniv.) - générale 06 2019-07-12 2019-07-05
TM (demande, 7e anniv.) - générale 07 2020-07-13 2020-06-23
TM (demande, 8e anniv.) - générale 08 2021-07-12 2021-07-05
Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
AMOREPACIFIC CORPORATION
Titulaires antérieures au dossier
JI HYE JANG
JIN KYU CHOI
JIN WOO PARK
JOON HO BAE
MIN KYOUNG KWON
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document (Temporairement non-disponible). Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.


Description du
Document 
Date
(yyyy-mm-dd) 
Nombre de pages   Taille de l'image (Ko) 
Description 2014-12-30 27 1 081
Abrégé 2014-12-30 1 10
Revendications 2014-12-30 6 157
Dessins 2014-12-30 7 115
Dessin représentatif 2014-12-30 1 13
Page couverture 2015-02-12 1 40
Revendications 2020-11-26 4 125
Revendications 2021-06-03 4 133
Description 2022-01-20 29 1 123
Abrégé 2022-01-20 1 10
Revendications 2022-01-20 5 136
Dessins 2022-01-20 7 235
Avis d'entree dans la phase nationale 2015-01-20 1 205
Rappel de taxe de maintien due 2015-03-15 1 111
Courtoisie - Lettre d'abandon (requête d'examen) 2018-08-22 1 167
Rappel - requête d'examen 2018-03-12 1 117
Accusé de réception de la requête d'examen 2019-07-10 1 186
Avis de retablissement 2019-07-10 1 168
Avis du commissaire - Demande jugée acceptable 2022-06-06 1 575
Avis du commissaire - non-paiement de la taxe de maintien en état pour une demande de brevet 2022-08-22 1 551
Courtoisie - Lettre d'abandon (AA) 2022-12-01 1 545
Courtoisie - Lettre d'abandon (taxe de maintien en état) 2023-02-22 1 551
Avis du commissaire - non-paiement de la taxe de maintien en état pour une demande de brevet 2023-08-22 1 551
PCT 2014-12-30 4 230
Changement de nomination d'agent 2016-03-29 1 33
Courtoisie - Lettre du bureau 2016-04-21 1 26
Rétablissement / Requête d'examen 2019-07-03 4 136
Demande de l'examinateur 2020-07-28 5 275
Modification / réponse à un rapport 2020-11-26 19 760
Demande de l'examinateur 2021-02-08 4 185
Modification / réponse à un rapport 2021-06-03 16 497
Demande de l'examinateur 2021-09-21 3 154
Modification / réponse à un rapport 2022-01-20 93 3 534